0002010024-24-000001.txt : 20240131 0002010024-24-000001.hdr.sgml : 20240131 20240131142933 ACCESSION NUMBER: 0002010024-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240131 DATE AS OF CHANGE: 20240131 EFFECTIVENESS DATE: 20240131 FILER: COMPANY DATA: COMPANY CONFORMED NAME: resistanceBio, Inc. CENTRAL INDEX KEY: 0002010024 ORGANIZATION NAME: IRS NUMBER: 872198379 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-504031 FILM NUMBER: 24582296 BUSINESS ADDRESS: STREET 1: 980 O'BRIEN DR CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 925-708-6165 MAIL ADDRESS: STREET 1: 980 O'BRIEN DR CITY: MENLO PARK STATE: CA ZIP: 94025 D 1 primary_doc.xml X0708 D LIVE 0002010024 resistanceBio, Inc. 980 O'BRIEN DR MENLO PARK CA CALIFORNIA 94025 925-708-6165 DELAWARE None None Corporation true 2021 NICHOLAS GOLDNER 980 O'BRIEN DR MENLO PARK CA CALIFORNIA 94025 Executive Officer Director CHRISTOPHER BULOW 980 O'BRIEN DR MENLO PARK CA CALIFORNIA 94025 Executive Officer Director KYLE LAPHAM 980 O'BRIEN DR MENLO PARK CA CALIFORNIA 94025 Executive Officer Director OMRI AMIRAV-DRORY 980 O'BRIEN DR MENLO PARK CA CALIFORNIA 94025 Director Pharmaceuticals Decline to Disclose 06b false 2024-01-29 false true true false 1 12776288 12776288 0 false 44 0 0 0 false resistanceBio, Inc. /s/Kyle Lapham Kyle Lapham Chief Executive Officer 2024-01-31